Cohen-Solal Martine, Funck-Brentano Thomas, Hay Eric
INSERM U606, University Paris-Diderot Paris 7, Lariboisière Hospital , Paris, France.
Bonekey Rep. 2013 Oct 2;2:422. doi: 10.1038/bonekey.2013.156.
Osteoarthritis characterizes the joint disease that results in cartilage damage accompanied by bone lesions and synovial inflammation. Joint integrity results from physiological interactions between all these tissues. Local factors such as cytokines and growth factors regulate cartilage remodeling and metabolism as well as chondrocyte differentiation and survival. Tremendous progress has been made through the use of animal models and provided insight for the mechanism of cartilage loss and chondrocyte functions. Surgical, chemical or genetic models have been developed to investigate the role of molecules in the pathogenesis or treatment of osteoarthritis. Indeed, the animal models are helpful to investigate the cartilage changes in relation to changes in bone remodeling. Increased bone resorption occurs at early stage of the development of osteoarthritis, the inhibition of which prevents cartilage damage, confirming the role of bone factors in the crosstalk between both tissues. Among these numerous molecules, some participate in the imbalance in cartilage homeostasis and in the pathophysiology of osteoarthritis. These local factors are potential candidates for new drug targets.
骨关节炎是一种关节疾病,会导致软骨损伤,并伴有骨病变和滑膜炎症。关节的完整性源于所有这些组织之间的生理相互作用。细胞因子和生长因子等局部因素调节软骨重塑和代谢以及软骨细胞的分化和存活。通过使用动物模型已经取得了巨大进展,并为软骨损失机制和软骨细胞功能提供了见解。已经开发出手术、化学或基因模型来研究分子在骨关节炎发病机制或治疗中的作用。事实上,动物模型有助于研究与骨重塑变化相关的软骨变化。在骨关节炎发展的早期阶段会出现骨吸收增加,抑制骨吸收可防止软骨损伤,这证实了骨因子在两种组织相互作用中的作用。在这些众多分子中,一些分子参与了软骨稳态的失衡和骨关节炎的病理生理学过程。这些局部因素是新药靶点的潜在候选者。